Deoxyribonucleoside triphosphate pools and adenosine toxicity.
D000241:Adenosine / Q000009:adverse effects*; D000243:Adenosine Deaminase / Q000378:metabolism; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001381:Azepines / Q000494:pharmacology; D002478:Cells, Cultured; D003854:Deoxyribonucleotides / Q000378:metabolism / Q000502:physiology*; D007939:Leukemia L1210 / Q000378:metabolism; D012263:Ribonucleosides / Q000494:pharmacology
D058892:Adenosine Deaminase Inhibitors; D000900:Anti-Bacterial Agents; D001381:Azepines; D003854:Deoxyribonucleotides; D012263:Ribonucleosides; D000243:Adenosine Deaminase; D000241:Adenosine